Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects

NCT00875524 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Dengue Virus
Dengue Fever
Dengue Hemorrhagic Fever
Dengue Disease

Interventions

BIOLOGICAL: CYD dengue vaccine serotypes (1, 2, 3, 4).
BIOLOGICAL: Meningococcal Polysaccharide A+C; NaCl; Typhoid Vi polysaccharide

Sponsor

Sanofi Pasteur, a Sanofi Company